Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Not like opioids, which bind to µ-opioid receptors from the central nervous method, conolidine modulates alternate molecular targets. A Science Developments research located that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://is-conolidine-available-o68901.jaiblogs.com/64722170/new-step-by-step-map-for-conolidin-to-replace-traditional-painkillers